
Keywords: AD; Alzheimer's disease; NMDAR; N-methyl-d-aspartate receptor; AMPAR; α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors; E/I; excitation/inhibition; EGFP; enhanced green fluorescent protein; PFC; prefrontal cortex; sEPSCs; spontaneous excita